(Q33948747)

30 July 2017

1 reference

title

Clinical perspectives on platinum resistance (English)

1 reference

30 July 2017

1 reference

Giaccone G

1

1 reference

30 July 2017

1 January 2000

1 reference

30 July 2017

1 reference

30 July 2017

59 Suppl 4

1 reference

30 July 2017

9-17; discussion 37-8

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200059004-00002

30 July 2017

0 references

cites work

Positive correlation between cellular glutathione and acquired cisplatin resistance in human ovarian cancer cells

1 reference

12 December 2020

ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy

1 reference

12 December 2020

Mature results of a randomized trial of two doses of cisplatin for the treatment of ovarian cancer. Scottish Gynecology Cancer Trials Group

1 reference

12 December 2020

Current sample handling methods for measurement of platinum-DNA adducts in leucocytes in man lead to discrepant results in DNA adduct levels and DNA repair

1 reference

12 December 2020

Clinical development of platinum complexes in cancer therapy: an historical perspective and an update.

1 reference

12 December 2020

Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment

1 reference

12 December 2020

Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy.

1 reference

12 December 2020

Evaluation of cisplatin and cyclosporin A in recurrent platinum-resistant ovarian cancer: a phase II study of the gynecologic oncology group

1 reference

12 December 2020

Relationship of LRP-human major vault protein to in vitro and clinical resistance to anticancer drugs

1 reference

12 December 2020

Responses to salvage chemotherapy in ovarian cancer: a critical need for precise definitions of the treated population

1 reference

12 December 2020

Drug resistance-associated marker Lrp for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma.

1 reference

12 December 2020

Glutathione depletion-induced thymidylate insufficiency for DNA repair synthesis

1 reference

12 December 2020

Prolonged administration of oral etoposide in patients with relapsed or refractory small-cell lung cancer: a phase II trial

1 reference

12 December 2020

Treatment of small cell lung cancer patients.

1 reference

12 December 2020

Platinum-DNA adducts in leukocyte DNA correlate with disease response in ovarian cancer patients receiving platinum-based chemotherapy

1 reference

12 December 2020

Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer.

1 reference

12 December 2020

hMLH1 expression and cellular responses of ovarian tumour cells to treatment with cytotoxic anticancer agents

1 reference

12 December 2020

New developments and approaches in the platinum arena

1 reference

12 December 2020

Randomised study of two doses of cisplatin with cyclophosphamide in epithelial ovarian cancer

1 reference

12 December 2020

Isolation of a novel human canalicular multispecific organic anion transporter, cMOAT2/MRP3, and its expression in cisplatin-resistant cancer cells with decreased ATP-dependent drug transport

1 reference

12 December 2020

Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy

1 reference

12 December 2020

Identification of new drugs in pretreated patients with small cell lung cancer

1 reference

12 December 2020

Clinical studies of reversal of drug resistance based on glutathione.

1 reference

12 December 2020

Noninvasive monitoring of drug biodistribution and metabolism: studies with intraarterial Pt-195m-cisplatin in humans

1 reference

12 December 2020

Intraperitoneal cis-diamminedichloroplatinum with systemic thiosulfate protection

1 reference

12 December 2020

Preclinical perspectives on platinum resistance

1 reference

12 December 2020

p53 and chemosensitivity.

1 reference

12 December 2020

Chemotherapy of advanced non-small cell lung cancer

1 reference

12 December 2020

The role of DNA mismatch repair in drug resistance.

1 reference

12 December 2020

Platinum resistance: laboratory findings and clinical implications

1 reference

12 December 2020

Cellular and molecular determinants of cisplatin resistance

1 reference

12 December 2020

Effect of glutathione on DNA repair in cisplatin-resistant human ovarian cancer cell lines.

1 reference

12 December 2020

Comparative pharmacokinetics, tissue distribution, and therapeutic effectiveness of cisplatin encapsulated in long-circulating, pegylated liposomes (SPI-077) in tumor-bearing mice.

1 reference

12 December 2020

Second-line chemotherapy and its evaluation in small cell lung cancer

1 reference

12 December 2020

Relationship between the exposure to cisplatin, DNA-adduct formation in leucocytes and tumour response in patients with solid tumours

1 reference

12 December 2020

Malignant and nonmalignant brain tissues differ in their messenger RNA expression patterns for ERCC1 and ERCC2.

1 reference

12 December 2020

Tailoring liposomes for cancer drug delivery: from the bench to the clinic

1 reference

12 December 2020

Chemotherapy of advanced ovarian cancer

1 reference

12 December 2020

Enhanced repair of a cisplatin-damaged reporter chloramphenicol-O-acetyltransferase gene and altered activities of DNA polymerases alpha and beta, and DNA ligase in cells of a human malignant glioma following in vivo cisplatin therapy

1 reference

12 December 2020

Cyclosporin A suppresses cisplatin-induced c-fos gene expression in ovarian carcinoma cells

1 reference

12 December 2020

A monoclonal antibody against the c-erbB-2 protein enhances the cytotoxicity of cis-diamminedichloroplatinum against human breast and ovarian tumor cell lines

1 reference

12 December 2020

Cisplatin resistance and DNA repair

1 reference

12 December 2020

Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II study

1 reference

12 December 2020

Loss of DNA mismatch repair in acquired resistance to cisplatin

1 reference

12 December 2020

Stages III and IV squamous cell carcinoma of the mouth: three-year experience with superselective intraarterial chemotherapy using cisplatin prior to definitive treatment

1 reference

12 December 2020

Sequential cycles of high-dose chemotherapy with dose escalation of carboplatin with or without paclitaxel supported by G-CSF mobilized peripheral blood progenitor cells: a phase I/II study in advanced ovarian cancer.

1 reference

12 December 2020

Maintenance chemotherapy in small-cell lung cancer: long-term results of a randomized trial. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group

1 reference

12 December 2020

Clinical pharmacokinetics and administration of established platinum drugs

1 reference

12 December 2020

Teniposide in the treatment of small-cell lung cancer: the influence of prior chemotherapy

1 reference

12 December 2020

High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis

1 reference

12 December 2020

Cellular glutathione (GSH) and glutathione S-transferase (GST) activity in human ovarian tumor biopsies following exposure to alkylating agents

1 reference

12 December 2020

10.2165/00003495-200059004-00002

Identifiers

DOI

0 references

Dimensions Publication ID

0 references

1 reference

PubMed ID

10864226